InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Wesche Holger, Directeur Scientifique. Director active across 1 companies, notably Harpoon Therapeutics, Inc.. In total, 2 filings have been published. The latest transaction was filed on 1 July 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€5,06510,000 shares@ €0.5065100.0% of flow
Common Stock
SEC:0001209191-21-045618·
€5,06510,000 shares@ €0.506550.0% of flow
Common Stock
SEC:0001209191-21-045618:0·
2 of 2 declarations
About Wesche Holger
Wesche Holger serves as Chief Scientific Officer at Harpoon Therapeutics, Inc. He is responsible for leading research and developing new treatments. Holger plays a key role in scientific innovation and implementing research strategies. His expertise in biotechnology is essential for the success of Harpoon Therapeutics.
